SCHEMBL165213

SCHEMBL165213

O=C(O)c1cccc(C(=O)O)c1C(=O)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.71
ALDH1A1 P00352 3/20 0.59
ALOX15 P16050 1/20 0.59
ATM Q13315 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
SRD5A2 P31213 1/20 0.56
CDC25B P30305 2/20 0.55
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
NR4A1 P22736 2/20 0.53
KDM4E B2RXH2 2/20 0.53
POLB P06746 1/20 0.53
NAPRT Q6XQN6 2/20 0.52
DAO P14920 1/20 0.52
TSHR P16473 1/20 0.52
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
CDC25A P30304 1/20 0.50
HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31432550 0.96 AKR1C3 (0.72) AKR1C3ALDH1A1ALOX15ATMTDP1
SCHEMBL30978151 0.89 AKR1C3 (0.76) AKR1C3ALDH1A1ALOX15ATMTDP1
SCHEMBL144047 0.89 AKR1C3 (0.76) AKR1C3ALDH1A1ALOX15ATMTDP1
SCHEMBL6056989 0.88 AKR1C3 (0.67) AKR1C3ALDH1A1ALOX15ATMTDP1
SCHEMBL857849 0.88 AKR1C3 (0.67) AKR1C3ALDH1A1ATMTDP1L3MBTL1
SCHEMBL30544840 0.87 ALDH1A1 (0.60) AKR1C3ALDH1A1ALOX15ATMCDC25B
Hydrochloric Acid SCHEMBL10626938 0.87 AKR1C3 (0.73) AKR1C3ALDH1A1ALOX15ATMTDP1
SCHEMBL1334177 0.87 AKR1C3 (0.61) AKR1C3ALDH1A1ALOX15ATMTDP1
SCHEMBL9774810 0.86 AKR1C3 (0.64) AKR1C3ALDH1A1ATMTDP1L3MBTL1
SCHEMBL5158216 0.86 AKR1C3 (0.59) AKR1C3ALDH1A1ALOX15ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042084-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP GENERAL ELECTRIC TECHNOLOGY GMBH (CH) 2026-02-12 US claimed
EP-4680369-A1 SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT GE Vernova Technology GmbH (CH) 2026-01-21 EP claimed
EP-4572884-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP General Electric Technology GmbH (CH) 2025-06-25 EP claimed
EP-4556112-A2 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS General Electric Technology GmbH (CH) 2025-05-21 EP claimed
CN-119869460-A Sorbent compositions, systems, and methods 通用电气技术有限公司 2025-04-25 CN claimed
US-12263464-B2 Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) 2025-04-01 US claimed
WO-2024232872-A1 SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT GENERAL ELECTRIC TECHNOLOGY GMBH (CH) 2024-11-14 WO claimed
US-20240199653-A1 METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-06-20 US claimed
WO-2024123903-A1 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS GE INFRASTRUCTURE TECHNOLOGY LLC (US) 2024-06-13 WO claimed
WO-2024039914-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP GENERAL ELECTRIC TECHNOLOGY GMBH (CH) 2024-02-22 WO claimed
EP-3801880-A1 METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFS), COVALENT ORGANIC FRAMEWORKS (COFS) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFS), AND APPLICATIONS THEREOF Desiccant Rotors International Private Ltd. (IN) 2021-04-14 EP claimed
US-20210016245-A1 METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFs), COVALENT ORGANIC FRAMEWORKS (COFs) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFs), AND APPLICATIONS THEREOF DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) 2021-01-21 US claimed
US-20200291045-A1 CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2020-09-17 US claimed
EP-2739169-B1 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS MASSACHUSETTS INST TECHNOLOGY (US) 2019-06-12 EP claimed
US-20140311507-A1 Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-10-23 US claimed
EP-0713501-B1 NAPHTHALENEDICARBOXYLIC ACID CONTAINING POLYMERS HAVING REDUCED FLUORESCENCE EASTMAN CHEM CO (US) 1997-04-23 EP claimed
US-20260138938-A1 SEPARATION METHOD DAIKIN INDUSTRIES, LTD. (JP) 2026-05-21 US disclosed
EP-4724195-A2 METAL-ORGANIC FRAMEWORK (MOF) COMPOSITIONS, PROCESS OF MAKING AND PROCESS OF USE THEREOF Numat Technologies Inc. (US) 2026-04-15 EP disclosed
WO-1995004777-A1 A PROCESS FOR PREPARING NAPHTHALENEDICARBOXYLIC ACID CONTAINING POLYMER BLENDS HAVING REDUCED FLUORESCENCE EASTMAN CHEMICAL COMPANY (US) 1995-02-16 WO disclosed
US-3933917-A Production of dimethylbenzophenone BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042084-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP SRMS, TYRO3, SELE AKR1C3 2789/4885ALDH1A1 3451/4885ALOX15 3885/4885
US-20260138938-A1 SEPARATION METHOD DCX, FGB, TPR AKR1C3 3093/4885ALDH1A1 2818/4885ALOX15 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.